Cas No.: | 1438492-26-2 |
Chemical Name: | Ciraparantag |
Synonyms: | Ciraparantag;PER977;Ciraparantag [USAN];Ciraparantag(PER977);U2R67KV65Q;Ciraparantag (USAN);Pentanamide, N,N'-(1,4-piperazinediyldi-3,1-propanediyl)bis[2-amino-5-[(aminoiminomethyl)amino]-, (2S,2'S)-;Aripazine;(2S,2'S)-N,N'-(piperazine-1,4-diylbis(propane-3,1-diyl))bis(2-amino-5-guanidinopentanamide);Pentanamide, N,N'-(1,4-piperazinediyldi-3,1-propanediyl)bis(2-amino-5-((aminoiminomethyl)amino)-, (2S,2'S)-;PER 977;SCHEMB |
SMILES: | O=C([C@H](CCC/N=C(\N)/N)N)NCCCN1CCN(CCCNC([C@H](CCC/N=C(\N)/N)N)=O)CC1 |
Formula: | C22H48N12O2 |
M.Wt: | 512.695722579956 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Ciraparantag is a thrombin and factor Xa inhibitors as well as to heparin-based anticoagulants through non-covalent hydrogen bonding and charge interactions. It is reported to antagonize the effects of all coagulants except VKAs and agratroban. [1][2] |